Skip to content
Inciteful Med

Genetics, Subtypes & Prognosis: How DNA Shapes the Disease

Last updated:

Primary Ciliary Dyskinesia (PCD) is caused by mutations in over 40 different genes, with DNAH5 and DNAH11 being the most common. A patient's specific genetic mutation directly impacts their long-term prognosis, lung health stability, and the likelihood of having mirrored organs.

Key Takeaways

  • • PCD is a genetically diverse condition involving over 40 different genes, with DNAH5 and DNAH11 being the most common mutations.
  • • A child's specific gene mutation strongly influences whether their lung function profile will be mild and stable or more progressive.
  • • Around 50% of PCD patients have Kartagener Syndrome, which includes mirrored internal organs (situs inversus) due to impaired embryonic nodal cilia.
  • • Early diagnosis before age 8 and preventing chronic bacterial infections like Pseudomonas aeruginosa are crucial for preserving long-term lung function.
  • • Doctors increasingly use the Lung Clearance Index (LCI) to detect subtle early changes in small airway health that standard breathing tests might miss.

Primary Ciliary Dyskinesia (PCD) is not a single disease, but a collection of many different genetic conditions that all lead to the same result: broken or ineffective cilia [1]. Because PCD is genetically heterogeneous (caused by many different genes), two children with PCD may have very different experiences based on their specific DNA [2].

The Role of Specific Genes

The “instruction manual” for cilia is complex, involving over 40 different genes [3]. The specific gene mutation your child has can act as a “roadmap” for their health:

  • DNAH5 & DNAH11: These are the most common mutations globally [4][5].
    • DNAH5 typically causes visible structural defects in the “arms” of the cilia [6].
    • DNAH11 is often “invisible” under standard microscopes because the cilia look normal even though they don’t move correctly [7][8]. Children with DNAH11 often have a more stable, milder lung function profile [9].
  • CCDC39 & CCDC40: These mutations are often associated with a more severe clinical phenotype [10]. Because these genes are responsible for the “skeleton” of the cilia, their absence leads to significant disorganized movement and a faster decline in lung function over time [11][12].

Understanding Situs Inversus and Embryology

About 50% of people with PCD have Kartagener Syndrome, which is the “triad” of chronic sinusitis, bronchiectasis (lung scarring), and situs inversus (mirrored organs) [13][14].

This happens during early pregnancy. In a developing embryo, specialized “nodal cilia” act like tiny propellers to push fluid to the left side of the body [6]. This fluid flow signals the heart, liver, and stomach where to grow. If these cilia don’t move, the body “guesses” the organ placement, resulting in a 50% chance of a completely mirrored layout (situs inversus totalis) or a more complex, disorganized layout called situs ambiguus (or heterotaxy) [6][15]. As mentioned earlier, heterotaxy requires immediate cardiac evaluation due to the high risk of severe congenital heart defects.

Long-Term Prognosis and Lung Health

While PCD is a lifelong condition, it is not necessarily a rapid decline.

  • Rate of Decline: In a large group of patients, the average decline in FEV1 (a measure of how much air you can blow out in one second) was only about 0.59% per year [16]. Many children maintain stable lung function for years [17].
  • Early Intervention: Diagnosing PCD before age 8 is linked to better preservation of height, weight, and lung function [18][19].
  • The Pseudomonas Factor: One of the most important goals in long-term care is preventing chronic infection with bacteria like Pseudomonas aeruginosa. This is a specific type of bacteria that thrives in wet environments like mucus-filled lungs. It is monitored via regular sputum cultures or throat swabs [20][21]. If it is detected, doctors have eradication protocols (specific antibiotics) to clear it, because chronic infection with this bacteria is linked to faster lung function decline in adults [20].

Monitoring for the Future

Doctors are increasingly using the Lung Clearance Index (LCI), a test that measures how well air moves through the small airways, to monitor children [22]. LCI is often more sensitive than standard breathing tests and can catch early changes in lung health before they show up on a traditional “blow test” [23][24].

Because PCD involves complex inheritance and fertility implications, consulting a genetic counselor is highly recommended to help you understand your family’s unique genetic blueprint and future risks [2].

Frequently Asked Questions

What are the most common gene mutations in primary ciliary dyskinesia?
The most common genetic mutations causing PCD worldwide are DNAH5 and DNAH11. DNAH5 usually causes visible structural defects in the cilia, while DNAH11 can look normal under a microscope but still causes movement issues.
What is Kartagener Syndrome?
Kartagener Syndrome affects about 50% of people with PCD. It is a specific triad of conditions that includes chronic sinusitis, lung scarring called bronchiectasis, and mirrored organ placement known as situs inversus.
Does having a specific PCD gene mutation predict my child's lung function?
Yes, the specific genetic mutation can act as a roadmap for your child's health. For example, CCDC39 and CCDC40 mutations are often associated with faster lung function decline, whereas DNAH11 mutations generally have a milder, more stable lung function profile.
What is the Lung Clearance Index (LCI) test for PCD?
The Lung Clearance Index is a breathing test that measures how well air moves through the small airways. It is often more sensitive than standard spirometry and can detect early changes in lung health before they appear on traditional tests.
Why is Pseudomonas aeruginosa dangerous for patients with PCD?
Pseudomonas aeruginosa is a type of bacteria that thrives in wet, mucus-filled lungs. Chronic infection with this bacteria is linked to a faster decline in lung function, which is why doctors monitor for it closely and use specific antibiotics to clear it.

Questions for Your Doctor

  • • Which specific genetic mutation was identified in my child, and is it one typically associated with a 'stable' or 'progressive' lung function profile?
  • • Since my child has a DNAH11 mutation, how will you monitor their ciliary function if standard structural tests (TEM) are normal?
  • • Given our child's genetics, what is the likelihood of other complications like congenital heart issues or hydrocephalus?
  • • Should we be using Lung Clearance Index (LCI) monitoring in addition to standard spirometry to catch early changes in lung health?
  • • What is our plan for preventing or managing chronic Pseudomonas aeruginosa colonization?

Questions for You

  • • Was our child diagnosed before age 8? If so, what steps can we take now to maintain the health advantages of an early diagnosis?
  • • Does my child have situs inversus (mirrored organs), and do we have clear imaging to share with other specialists or emergency providers?
  • • Are we noticing any symptoms of 'exacerbations,' such as a change in cough or energy level, that might indicate a temporary drop in lung function?
  • • How can we best support our child’s growth (height and BMI) to help protect their long-term lung health?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Diagnosis of primary ciliary dyskinesia: summary of the ERS Task Force report.

    Kuehni CE, Lucas JS

    Breathe (Sheffield, England) 2017; (13(3)):166-178 doi:10.1183/20734735.008517.

    PMID: 28894478
  2. 2

    Clinical and genetic spectrum of primary ciliary dyskinesia in Chinese patients: a systematic review.

    Peng B, Gao YH, Xie JQ, et al.

    Orphanet journal of rare diseases 2022; (17(1)):283 doi:10.1186/s13023-022-02427-1.

    PMID: 35854386
  3. 3

    Homozygous truncating NEK10 mutation, associated with primary ciliary dyskinesia: a case report.

    Al Mutairi F, Alkhalaf R, Alkhorayyef A, et al.

    BMC pulmonary medicine 2020; (20(1)):141 doi:10.1186/s12890-020-1175-1.

    PMID: 32414360
  4. 4

    Heterogeneity of Primary Ciliary Dyskinesia Gene Variants: A Genetic Database Analysis in Russia.

    Kondratyeva EI, Avdeev SN, Kyian TA, et al.

    International journal of molecular sciences 2025; (26(23)) doi:10.3390/ijms262311674.

    PMID: 41373829
  5. 5

    Genetic Spectrum and Clinical Characteristics of Patients with Primary Ciliary Dyskinesia: a Belgian Single Center Study.

    Rodriguez Mier N, Jaspers M, Van Hoof E, et al.

    Lung 2024; (202(3)):291-298 doi:10.1007/s00408-024-00696-0.

    PMID: 38602513
  6. 6

    Randomization of Left-right Asymmetry and Congenital Heart Defects: The Role of DNAH5 in Humans and Mice.

    Nöthe-Menchen T, Wallmeier J, Pennekamp P, et al.

    Circulation. Genomic and precision medicine 2019; doi:10.1161/CIRCGEN.119.002686.

    PMID: 31638833
  7. 7

    Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure.

    Shapiro AJ, Leigh MW

    Ultrastructural pathology 2017; (41(6)):373-385 doi:10.1080/01913123.2017.1362088.

    PMID: 28915070
  8. 8

    Primary ciliary dyskinesia: a case report of double DNAH11 mutant alleles.

    Pîrlog LM, Pătrăşcanu AA, Kutasi E, et al.

    Medicine and pharmacy reports 2025; (98(2)):252-256 doi:10.15386/mpr-2743.

    PMID: 40371404
  9. 9

    Long-Term Lung Function and Pseudomonas aeruginosa Infection in Genotyped Primary Ciliary Dyskinesia.

    Holgersen MG, Marthin JK, Raidt J, et al.

    Annals of the American Thoracic Society 2025; (22(2)):216-225 doi:10.1513/AnnalsATS.202404-340OC.

    PMID: 39447114
  10. 10

    Genotype-Phenotype Correlation in a Group of Italian Patients With Primary Ciliary Dyskinesia.

    Petrarca L, Guida V, Nenna R, et al.

    Pediatric pulmonology 2025; (60(4)):e71057 doi:10.1002/ppul.71057.

    PMID: 40183288
  11. 11

    Undocking of an extensive ciliary network induces proteostasis and cell fate switching resulting in severe primary ciliary dyskinesia.

    Brody SL, Pan J, Huang T, et al.

    Science translational medicine 2025; (17(783)):eadp5173 doi:10.1126/scitranslmed.adp5173.

    PMID: 39879322
  12. 12

    Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis.

    Kinghorn B, Rosenfeld M, Sullivan E, et al.

    Annals of the American Thoracic Society 2024; (21(12)):1723-1732 doi:10.1513/AnnalsATS.202311-1008OC.

    PMID: 39383539
  13. 13

    Proceedings of the 3rd BEAT-PCD Conference and 4th PCD Training School.

    Farley H, Rubbo B, Bukowy-Bieryllo Z, et al.

    BMC proceedings 2018; (12(Suppl 16)):64 doi:10.1186/s12919-018-0161-6.

    PMID: 30807620
  14. 14

    A case of Kartagener syndrome with rhinolalia clausa.

    Raoufi M, Sator H, Lahma J, et al.

    The Pan African medical journal 2016; (23()):159 doi:10.11604/pamj.2016.23.159.8664.

    PMID: 27375831
  15. 15

    LRRC56 deletion causes primary ciliary dyskinesia in mice characterized by dynein arms defects.

    Wu R, Li H, Wu P, et al.

    Biology open 2025; (14(2)) doi:10.1242/bio.061846.

    PMID: 39912490
  16. 16

    An international registry for primary ciliary dyskinesia.

    Werner C, Lablans M, Ataian M, et al.

    The European respiratory journal 2016; (47(3)):849-59 doi:10.1183/13993003.00776-2015.

    PMID: 26659107
  17. 17

    Lung function from school age to adulthood in primary ciliary dyskinesia.

    Halbeisen FS, Pedersen ESL, Goutaki M, et al.

    The European respiratory journal 2022; (60(4)) doi:10.1183/13993003.01918-2021.

    PMID: 35301251
  18. 18

    The Impact of Age of Diagnosis in Children with Primary Ciliary Dyskinesia.

    Gatt D, Shaw M, Kritzinger F, et al.

    Annals of the American Thoracic Society 2025; (22(2)):208-215 doi:10.1513/AnnalsATS.202403-230OC.

    PMID: 39269367
  19. 19

    Growth and nutritional status, and their association with lung function: a study from the international Primary Ciliary Dyskinesia Cohort.

    Goutaki M, Halbeisen FS, Spycher BD, et al.

    The European respiratory journal 2017; (50(6)) doi:10.1183/13993003.01659-2017.

    PMID: 29269581
  20. 20

    A longitudinal study characterising a large adult primary ciliary dyskinesia population.

    Shah A, Shoemark A, MacNeill SJ, et al.

    The European respiratory journal 2016; (48(2)):441-50 doi:10.1183/13993003.00209-2016.

    PMID: 27288033
  21. 21

    Primary ciliary dyskinesia in Volendam: Diagnostic and phenotypic features in patients with a CCDC114 mutation.

    Kos R, Israëls J, van Gogh CDL, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(1)):89-101 doi:10.1002/ajmg.c.31968.

    PMID: 35343062
  22. 22

    Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.

    Kinghorn B, McNamara S, Genatossio A, et al.

    Annals of the American Thoracic Society 2020; (17(9)):1085-1093 doi:10.1513/AnnalsATS.201905-375OC.

    PMID: 32603187
  23. 23

    Repeatability of Multiple Breath Washout in Pediatric Primary Ciliary Dyskinesia.

    Wee WB, Bashi LM, Jensen R, et al.

    Pediatric pulmonology 2025; (60(7)):e71107 doi:10.1002/ppul.71107.

    PMID: 40642924
  24. 24

    Structural and Functional Lung Impairment in Primary Ciliary Dyskinesia. Assessment with Magnetic Resonance Imaging and Multiple Breath Washout in Comparison to Spirometry.

    Nyilas S, Bauman G, Pusterla O, et al.

    Annals of the American Thoracic Society 2018; (15(12)):1434-1442 doi:10.1513/AnnalsATS.201712-967OC.

    PMID: 30290127

This page provides educational information about Primary Ciliary Dyskinesia (PCD) genetics and prognosis. It is not medical advice. Always consult your pulmonologist or genetic counselor to understand how your specific gene mutations affect your care.

Stay up to date

Get notified when new research about Primary ciliary dyskinesia is published.

No spam. Unsubscribe anytime.